| Literature DB >> 21507256 |
Bruno Salaun1, Takuya Yamamoto, Bassam Badran, Yasuko Tsunetsugu-Yokota, Antoine Roux, Lukas Baitsch, Redouane Rouas, Hussein Fayyad-Kazan, Petra Baumgaertner, Estelle Devevre, Anirudh Ramesh, Marion Braun, Daniel Speiser, Brigitte Autran, Philippe Martiat, Victor Appay, Pedro Romero.
Abstract
BACKGROUND: The differentiation of CD8+ T lymphocytes following priming of naïve cells is central in the establishment of the adaptive immune response. Yet, the molecular events underlying this process are not fully understood. MicroRNAs have been recently shown to play a key role in the regulation of haematopoiesis in mouse, but their implication in peripheral lymphocyte differentiation in humans remains largely unknown.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21507256 PMCID: PMC3098162 DOI: 10.1186/1479-5876-9-44
Source DB: PubMed Journal: J Transl Med ISSN: 1479-5876 Impact factor: 5.531
Figure 1Sorting of human CD8. a) CD8+ T cells from healthy volunteers were FACS-sorted based on their expression of CD45RA, CCR7 and CD28 to isolate Naive (CD45RA+ CCR7+, CD28+), E-EM (CD45RA- CCR7-, CD28+), I-EM (CD45RA- CCR7-, CD28-) and L-EM (CD45RA+ CCR7-, CD28-). Data shown are gated on CD3+ CD8+ cells. b) Unsupervised clustering of the expression levels (ΔCt, normalized to RNU44) of 223 unique microRNAs (detected in at least one sample, i.e. Ct < 36) in CD8+ T lymphocyte subsets from 3 healthy donors (HD1, HD2, HD3) as measured by TLDA (green: low expression/red: high expression).
Human CD8+ T cells express a limited set of microRNA
| Group A | GROUP B | ||
|---|---|---|---|
| hsa-miR-142-3p | hsa-miR-31 | ||
| hsa-miR-26a | hsa-miR-125a | ||
| hsa-miR-16 | hsa-miR-565 | ||
| hsa-miR-26b | hsa-let-7b | ||
| hsa-miR-146b | hsa-let-7a | ||
| hsa-miR-29a | hsa-miR-181b | ||
| hsa-miR-19b * | hsa-miR-30e-3p | ||
| hsa-miR-92 * | hsa-miR-423 | ||
| hsa-miR-342 | hsa-miR-328 | ||
| hsa-miR-30c | hsa-miR-101 | ||
| hsa-miR-20a * | hsa-miR-223 | ||
| hsa-let-7g | hsa-miR-27a | ||
| hsa-miR-142-5p | hsa-miR-25 * | ||
| hsa-miR-146a | hsa-miR-195 | ||
| hsa-miR-24 | hsa-miR-425-5p | ||
| hsa-miR-21 | hsa-miR-222 | ||
| hsa-miR-29c | hsa-miR-197 | ||
| hsa-miR-30b | hsa-miR-28 | ||
| hsa-miR-30a-5p | hsa-miR-186 | ||
| hsa-miR-191 | hsa-miR-331 | ||
| hsa-miR-484 | hsa-miR-192 | ||
| hsa-miR-140 | hsa-miR-103 | ||
| hsa-miR-594 | |||
| hsa-miR-15b | |||
| hsa-miR-30e-3p | |||
| hsa-miR-155 | |||
| hsa-miR-374 | |||
| hsa-miR-93 * | |||
| hsa-miR-19a * | |||
| hsa-miR-106b * | |||
| hsa-miR-30d | |||
MicroRNA ranking according to relative expression in CD8+ T cells. Groups A and B are as identified by unsupervised clustering in Figure 1b. *: microRNA belonging to the miR-17~92 cluster.
Figure 2miR-21 and miR-155 are upregulated in differentiated CD8. a) Unsupervised heatmap clustering of the expression levels of a selected set of microRNAs in each subset normalized to levels in naive cells (log2 fold change) (green: downregulated/red: upregulated). b) Expression levels of miR-21 and miR-155 in sorted human CD8+ T cell subsets were determined by single specific qPCR performed in triplicates, and are expressed as fold change relatively to levels in naive cells (n = 8; *: p < 0,05; **: p < 0,01).
Figure 3The miR-17~92 cluster is preferentially downregulated in differentiated CD8. Expression levels of miR-155 (a), miR-142.3p and miR-142-5p (b) and of members of the miR-17~92 cluster (c) were determined by single specific qPCR in the indicated sorted human CD8+ T cell subsets (a), and are expressed as fold change relatively to levels in naive cells (n = 9; *: p < 0,05; **: p < 0,01).